Trials / Completed
CompletedNCT00601809
(Gastrografin Use in Small Bowel Obstruction Caused by Adherences)
Gastrografin Use in Small Bowel Obstruction Caused by Adherences
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- University of Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Adhesive small intestine obstruction (ASIO) is an important cause of hospital admission and a very common disease. Any improvement in this field will benefit many patients by reducing the operative rate. Patients with this disease are difficult to evaluate and to manage and their treatment is controversial. Emergency surgery is mandatory when strangulation is suspected or in the case of total obstruction. On the other hand, conservative non-operative treatment is indicated in the case of partial obstruction. The role of water-soluble contrast medium (Gastrografin®: GG) in ASIO is still debated with regard to the therapeutic value. The aim of our study was to determine the therapeutic role of Gastrografin in patients with small intestine obstruction without strangulation caused by adherences (ASIO).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | traditional conservative treatment (TT) | In the control group (TT: Traditional Treatment), the patients have been treated as in our daily surgical practice of traditional conservative treatment for ASIO, consisting in nil per os diet, nasogastric tube (NGT) decompression and intravenous fluid resuscitation therapy with electrolytes imbalances correction. |
| DRUG | Gastrografin®: G | The study group (GG: Gastrografin Group) received, beyond the traditional conservative treatment for ASIO above mentioned, a G meal with a follow-through study immediately. |
Timeline
- Start date
- 2003-09-01
- Completion
- 2006-11-01
- First posted
- 2008-01-28
- Last updated
- 2008-01-28
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00601809. Inclusion in this directory is not an endorsement.